1. Home
  2. ENS vs BLCO Comparison

ENS vs BLCO Comparison

Compare ENS & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EnerSys

ENS

EnerSys

N/A

Current Price

$139.91

Market Cap

5.4B

Sector

Technology

ML Signal

N/A

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

N/A

Current Price

$16.86

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ENS
BLCO
Founded
1991
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Ophthalmic Goods
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
6.0B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
ENS
BLCO
Price
$139.91
$16.86
Analyst Decision
Strong Buy
Hold
Analyst Count
3
14
Target Price
$151.33
$17.31
AVG Volume (30 Days)
465.9K
389.3K
Earning Date
02-04-2026
10-29-2025
Dividend Yield
0.72%
N/A
EPS Growth
21.73
N/A
EPS
8.58
N/A
Revenue
$3,725,304,000.00
$4,976,000,000.00
Revenue This Year
$4.71
$8.08
Revenue Next Year
$2.75
$5.77
P/E Ratio
$16.87
N/A
Revenue Growth
6.17
6.23
52 Week Low
$76.57
$10.45
52 Week High
$152.01
$18.99

Technical Indicators

Market Signals
Indicator
ENS
BLCO
Relative Strength Index (RSI) 47.87 58.10
Support Level $145.00 $16.83
Resistance Level $151.37 $17.33
Average True Range (ATR) 3.78 0.44
MACD -1.16 0.01
Stochastic Oscillator 11.49 49.70

Price Performance

Historical Comparison
ENS
BLCO

About ENS EnerSys

EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: